{"id":104350,"date":"2023-06-21T14:25:39","date_gmt":"2023-06-21T08:55:39","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=104350"},"modified":"2023-06-21T15:33:01","modified_gmt":"2023-06-21T10:03:01","slug":"pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/","title":{"rendered":"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-934660629\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2887340563\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The stocks showed a movement after the company, through a regulatory filing with the BSE today, announced that it has received approval from the United States Food &amp; Drug Administration (USFDA) pertaining to a new drug application for \u2018Tiotropium Bromide Inhalation Powder\u2019. Manufacturing of the same will be done at the company\u2019s Pithampur facility based in India.&nbsp;<\/p><p>\u201cWe are delighted to receive the final approval for generic Spiriva\u00ae HandiHaler from the U.S. FDA. This builds on our commitment to serving unmet needs for our patients across the world. This is the first generic approval for Spiriva\u00ae HandiHaler in the U.S., and is also the first DPI approval from India for the U.S. This is an important milestone in our journey of building our respiratory franchise globally\u201d, mentioned Ms. Vinita Gupta, Chief Executive Officer of Lupin.&nbsp;<\/p><p>The latest financial results, on a consolidated basis, represent an increase in the operating revenues from Rs 16,405 crores during FY21-22 to Rs 16,641 crores in FY22-23.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-6856314\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Moreover, the company has been successful in bouncing back its cost management strategies and boosting its earnings, taking a shift from net losses of Rs 1,509 crores during FY21-22 to net profits of Rs 447 crores in FY22-23.&nbsp;<\/p><p>The latest shareholding data available for the March 2023 quarter exhibits the Promoters holding a 47.08 percent stake, and Foreign Institutional Investors (FIIs) holding a 13.32 percent stake in the company.&nbsp;<\/p><p>Lupin Limited is engaged in the business of developing and delivering a wide range of generic as well as branded formulations on a global level. The majority of its revenues are generated from the US markets, followed by India.&nbsp;<\/p><p><strong>Written by Amit Madnani<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-1877091589\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31],"tags":[],"class_list":["post-104350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0\" \/>\n<meta property=\"og:description\" content=\"With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-21T08:55:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-21T10:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/\",\"name\":\"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-06-21T08:55:39+00:00\",\"dateModified\":\"2023-06-21T10:03:01+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0 - Trade Brains Features","description":"With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0","og_description":"With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-06-21T08:55:39+00:00","article_modified_time":"2023-06-21T10:03:01+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/","name":"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-06-21T08:55:39+00:00","dateModified":"2023-06-21T10:03:01+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"With a market capitalization of Rs 39,968 crores, the shares of Lupin Limited started its trading session today at Rs 832 and currently trade at Rs 878, exhibiting a gain of around 6 percent compared to the previous closing levels of Rs 829.90. The scrip witnessed its fresh 52-week high at a price of Rs 885.30.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-receiving-approval-for-a-new-drug-from-us-fda-hits-52-week-high\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 6% after receiving approval for a new drug from US FDA; Hits 52-week high\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/104350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=104350"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/104350\/revisions"}],"predecessor-version":[{"id":104351,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/104350\/revisions\/104351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=104350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=104350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=104350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}